All Updates

WASHINGTON, D.C. – Today, the American Cancer Society Cancer Action Network (ACS CAN) led an amicus (or friend-of-the-court) brief on behalf of key national public health groups in support of plaintiffs in the American Academy of Pediatrics v. Kennedy lawsuit. This case is pending at the U.S. Court

A coalition of public health organizations, pediatricians and parents today filed a federal lawsuit challenging the Food and Drug Administration’s new enforcement policy that allows e-cigarette and nicotine pouch products to be marketed and sold without the scientific review and marketing authorization required by federal law.

A coalition of public health organizations, pediatricians and parents today filed a federal lawsuit challenging the Food and Drug Administration’s new enforcement policy that allows e-cigarette and nicotine pouch products to be marketed and sold without the scientific review and marketing authorization required by federal law.

The San Francisco Board of Supervisors passed an ordinance to exempt “cannabis cafes” from the smoke-free law. This jeopardizes public health and rolls back decades of hard-won protections of workers’ right to breathe clean, smoke-free air.

The San Francisco Board of Supervisors passed an ordinance to exempt “cannabis cafes” from the smoke-free law. This jeopardizes public health and rolls back decades of hard-won protections of workers’ right to breathe clean, smoke-free air.

Today, the American Cancer Society and the American Cancer Society Cancer Action Network submitted a comment letter to the Office of Management and Budget strongly opposing a proposed rule that would change the federal government’s grantmaking framework.

Today, the American Cancer Society and the American Cancer Society Cancer Action Network submitted a comment letter to the Office of Management and Budget strongly opposing a proposed rule that would change the federal government’s grantmaking framework.

Nearly 200 patient advocacy, public health and health care professional organizations sent a letter to the Senate declaring their strong support for the Clinical Trial Modernization Act (S. 4440/H.R. 3521). The bipartisan, bicameral legislation would help remove cost and geographic barriers that keep patients from enrolling and participating in clinical trials. The bill was introduced in the U.S. Senate by Sens. Tim Scott (R-SC) and Mark Warner (D-VA) in April 2026 and in the U.S. House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-TX).

Nearly 200 patient advocacy, public health and health care professional organizations sent a letter to the Senate declaring their strong support for the Clinical Trial Modernization Act (S. 4440/H.R. 3521). The bipartisan, bicameral legislation would help remove cost and geographic barriers that keep patients from enrolling and participating in clinical trials. The bill was introduced in the U.S. Senate by Sens. Tim Scott (R-SC) and Mark Warner (D-VA) in April 2026 and in the U.S. House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-TX).